Brexit Could Quell UK’s Voice In EU Medtech Regs Debate
This article was originally published in Clinica
Executive Summary
The UK has always been a highly active authority in leading discussions and initiating action in the EU medtech regulatory space. Arguably, along with France, it has been the most active among its other EU counterparts. So what will the UK’s influence be if it votes to leave the EU during the June 23 referendum and would the EU’s medtech rules still apply? Clinica’s Amanda Maxwell sought the opinions of Alexander Denoon and Erik Vollebregt.
You may also be interested in...
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.
Non-Medical Brain Stimulation Devices: Could They Be Down-Classified Again In the EU?
Six types of products that do not have an intended medical purpose fall under the scope of the Medical Device Regulation. Understanding their risks is complex and subject to regular re-examination by the European Commission.